Incidence and risk factors for cutaneous adverse drug reactions in an intensive care unit

被引:0
|
作者
Campos-Fernández, MDM
Ponce-De-Leóon-Rosales, S
Archer-Dubon, C
Orozco-Topete, R
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Dermatol, Mexico City 14080, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hosp Epidemiol, Mexico City 14080, DF, Mexico
关键词
cutaneous drug reactions; hospital epidemiology; intensive care unit;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To evaluate the incidence of adverse cutaneous drug reactions in intensive care unit patients. Design. Cohort study. Setting. General adult intensive care unit of an institutional tertiary care hospital. Patients. Patients in the intensive care unit during a consecutive 8-month period were examined for adverse cutaneous drug reactions. Results. Patients in the intensive care unit have an incidence of 11.6% of adverse cutaneous drug reactions. Associated risk factors were female gender, obesity, age over 60 and immune dysregulation (systemic lupus erythematosus, dysthyroidism, and antiphospholipid antibodies syndrome). Few patients had previous history of adverse cutaneous drug reactions. Antimicrobials were the main drug involved. Morbilliform, rash followed by urticary were the most frequently observed reactions. Interestingly, over 50% of patients with massive edema -independent of etiology-died. Conclusions. Intensive care unit patients are particularly at risk for developing an adverse cutaneous drug reaction.
引用
收藏
页码:770 / 774
页数:5
相关论文
共 50 条
  • [1] Incidence and Severity of Adverse Drug Reactions in Medical Intensive Care Unit
    Shaikh, Sana
    Raut, Asawari
    Jambhale, Prajkta
    Iyer, Shivkumar
    Shah, Jignesh
    CURRENT DRUG SAFETY, 2024, 19 (03) : 332 - 341
  • [2] Adverse Drug Reactions in an Intensive Care Unit
    Grenouillet-Delacre, M.
    Lecomte, C.
    Daveluy, A.
    Miremont-Salame, G.
    Castaing, Y.
    Haramburu, F.
    DRUG SAFETY, 2009, 32 (10) : 977 - 977
  • [3] Incidence and Costs of Adverse Drug Reactions in a Tertiary Care Pediatric Intensive Care Unit
    Du, Wei
    Lehr, Victoria Tutag
    Caverly, Mary
    Kelm, Lauren
    Reeves, Jaxk
    Lieh-Lai, Mary
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (05): : 567 - 573
  • [4] Epidemiology of adverse drug reactions in an intensive care unit
    Laura, Canadell
    Rocio, Pardo
    Carmen, Gilabert M.
    Angeles, Ruiz M.
    Santiago, Alonso
    Enrique, Perez
    Jesus, Gallart M.
    Jordi, Rello
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 715 - 715
  • [5] Risk factors for adverse drug reactions in patients admitted to intensive care units
    Obreque, Karin
    Mellado, Rosemarie
    Andresen, Max
    REVISTA MEDICA DE CHILE, 2021, 149 (09) : 1258 - 1266
  • [6] INCIDENCE AND OUTCOME OF ADVERSE DRUG-REACTIONS IN A NEWBORN INTENSIVE-CARE UNIT (NICU)
    ARANDA, JV
    PORTUGUEZMALAVASI, A
    COLLINGE, J
    OUTERBRIDGE, EW
    PEDIATRIC RESEARCH, 1979, 13 (04) : 366 - 366
  • [7] Adverse drug reactions resulting in hyperthermia in the intensive care unit
    McAllen, Karen J.
    Schwartz, David R.
    CRITICAL CARE MEDICINE, 2010, 38 : S244 - S252
  • [8] Genetic predisposition to adverse drug reactions in the intensive care unit
    Empey, Philip E.
    CRITICAL CARE MEDICINE, 2010, 38 : S106 - S116
  • [9] Constipation in intensive care unit: Incidence and risk factors
    Nassar, Antonio Paulo, Jr.
    Queiroz da Silva, Fernanda Maria
    de Cleva, Roberto
    JOURNAL OF CRITICAL CARE, 2009, 24 (04) : 630.e9 - 630.e12
  • [10] Incidence and risk factors for hypercalcemia in intensive care unit
    Gagnon, N
    Lauzier, F
    LeBlanc, FJ
    CHEST, 2005, 128 (04) : 300S - 300S